SCHEMBL21158807

SCHEMBL21158807

O=C(O)NC(c1ccccc1Cl)C1CCCCC1=O

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA1 P00915 6/20 0.57
MAPT P10636 2/20 0.51
KDM4E B2RXH2 2/20 0.51
HPGD P15428 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
LMNA P02545 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MCL1 Q07820 1/20 0.40
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.40
CA2 P00918 1/20 0.40
OPRL1 P41146 2/20 0.39
OPRM1 P35372 1/20 0.39
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29088816 0.86 CA1 (0.51) CA1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL29088778 0.79 CA1 (0.44) CA1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL3486328 0.78 CA1 (0.51) CA1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL13254537 0.78 CA1 (0.51) CA1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL13254458 0.74 MAPT (0.54) CA1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL13254459 0.74 MAPT (0.54) CA1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL3486103 0.74 MAPT (0.54) CA1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL29088785 0.73 CA1 (0.44) CA1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL5373025 0.72 CA1 (0.48) CA1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL29065882 0.71 LMNA (0.42) CA1MAPTKDM4EHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3908571-A1 KETAMINE DERIVATIVES AND COMPOSITIONS THEREOF XWPharma Ltd. (KY) 2021-11-17 EP claimed
WO-2020143198-A1 KETAMINE DERIVATIVES AND COMPOSITIONS THEREOF XW LABORATORIES INC. (KY) 2020-07-16 WO claimed
EP-3908571-A1 KETAMINE DERIVATIVES AND COMPOSITIONS THEREOF XWPharma Ltd. (KY) 2021-11-17 EP disclosed
EP-3737665-A1 PRODRUGS OF KETAMINE, COMPOSITIONS AND USES THEREOF XW Laboratories Inc. (KY) 2020-11-18 EP disclosed
WO-2020143198-A1 KETAMINE DERIVATIVES AND COMPOSITIONS THEREOF XW LABORATORIES INC. (KY) 2020-07-16 WO disclosed
WO-2019137381-A1 PRODRUGS OF KETAMINE, COMPOSITIONS AND USES THEREOF XW LABORATORIES, INC. (CN) 2019-07-18 WO disclosed